Mostrar el registro sencillo del ítem
dc.contributor.author | Sizaire, Vinciane | |
dc.contributor.author | Garrido-Estepa, Macarena | |
dc.contributor.author | Masa-Calles, Josefa | |
dc.contributor.author | Martinez de Aragon-Esquivias, Maria Victoria | |
dc.date.accessioned | 2020-02-03T08:57:40Z | |
dc.date.available | 2020-02-03T08:57:40Z | |
dc.date.issued | 2014-08-14 | |
dc.identifier.citation | Euro Surveill. 2014 Aug 14;19(32). pii: 20875. | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/9003 | |
dc.description.abstract | In Spain, whole cell pertussis vaccination started in 1975, with three doses before the age of 6-7 months. Doses at 15-18 months and 4-6 years were introduced in 1996 and 2001, respectively. Spain switched to an acellular vaccine in 2005. From 1998 to 2009, pertussis incidence rates remained ≤1.5 cases/100,000 inhabitants but increased from 2010 to 7.5 cases/100,000 in 2012. Data from 1998 to 2012 were analysed to assess disease trends and susceptible populations. We defined four epidemic periods: 1998-2001 (reference), 2002-05, 2006-09 and 2010-12. In 2002-05, the incidence rate increased in individuals aged 15-49 years (IRR: 1.41 (95% CI: 1.11-1.78)) and ≥50 years (IRR: 2.78 (95% CI: 1.78-4.33)) and in 2006-09 increased also in infants aged <3 months (IRR: 1.83 (95% CI: 1.60-2.09)). In 2010-12, the incidence rate increased notably in all age groups, with IRRs ranging between 2.5 (95% CI: 2.3-2.8) in 5-9 year-olds and 36.0 (95% CI: 19.4-66.8) in 20-29 year-olds. These results, consistent with the country's vaccination history, suggest a progressive accumulation of susceptible individuals due to waning immunity after years of low incidence. Further vaccination strategies should be assessed and implemented to prevent pertussis in pre-vaccinated infants, in whom the disease is more severe. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | European Centre for Disease Prevention and Control (ECDC) | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject.mesh | Adolescent | es_ES |
dc.subject.mesh | Adult | es_ES |
dc.subject.mesh | Age Distribution | es_ES |
dc.subject.mesh | Bordetella pertussis | es_ES |
dc.subject.mesh | Child | es_ES |
dc.subject.mesh | Child, Preschool | es_ES |
dc.subject.mesh | Epidemics | es_ES |
dc.subject.mesh | Female | es_ES |
dc.subject.mesh | Hospitalization | es_ES |
dc.subject.mesh | Humans | es_ES |
dc.subject.mesh | Immunization Programs | es_ES |
dc.subject.mesh | Incidence | es_ES |
dc.subject.mesh | Infant | es_ES |
dc.subject.mesh | Infant, Newborn | es_ES |
dc.subject.mesh | Male | es_ES |
dc.subject.mesh | Middle Aged | es_ES |
dc.subject.mesh | Pertussis Vaccine | es_ES |
dc.subject.mesh | Population Surveillance | es_ES |
dc.subject.mesh | Spain | es_ES |
dc.subject.mesh | Time Factors | es_ES |
dc.subject.mesh | Whooping Cough | es_ES |
dc.subject.mesh | Young Adult | es_ES |
dc.title | Increase of pertussis incidence in 2010 to 2012 after 12 years of low circulation in Spain | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Atribución 4.0 Internacional | * |
dc.identifier.pubmedID | 25139074 | es_ES |
dc.format.volume | 19 | es_ES |
dc.format.number | 32 | es_ES |
dc.identifier.doi | 10.2807/1560-7917.es2014.19.32.20875 | es_ES |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 1560-7917 | es_ES |
dc.relation.publisherversion | https://doi.org/10.2807/1560-7917.es2014.19.32.20875 | es_ES |
dc.identifier.journal | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Epidemiología | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.rights.accessRights | open access | es_ES |